Esmail Mutahar Al-Ezzi

A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS)

Jeremy Lewin, Eoghan Malone, Esmail Mutahar Al-Ezzi et al. · European Journal of Cancer · 2021 · 15 citations

Medicine, Oncology, Pharmacology +14

Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer

Mahmoud Zaki El-Readi, Ahmad A. Mirza, Sameer Hasan Fatani et al. · Oncology Research and Treatment · 2020 · 12 citations

Medicine, Biochemistry, Oncology +13

The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma

Abhenil Mittal, Esmail Mutahar Al-Ezzi, Xuan Li et al. · British Journal of Cancer · 2023 · 12 citations · Full text

Medicine, Oncology, Metastasis +12

A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study

Abdulazeez Salawu, Aaron R. Hansen, Anna Spreafico et al. · Targeted Oncology · 2022 · 11 citations

Medicine, Genetics, Oncology +10

Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223

Esmail Mutahar Al-Ezzi, Husam Alqaisi, Marco Iafolla et al. · Cancer Medicine · 2021 · 10 citations · Full text

Medicine, Oncology, Radiation Oncology +17